Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
All Stories

Technology

1029 articles · sorted by newest first

AllAI & SocietyBig Tech & MarketsScience & SpaceCyber & Privacy

Latest in Technology

Latest in Technology
20 results
Technology 6/16/2026

What Canadian health IT buyers want before they sign

A new survey of 212 Canadian healthcare IT leaders reveals a seismic shift in procurement demands, with buyers now requiring concrete proof from vendors on critical fronts: strict interoperability, robust Canadian data sovereignty, explicit AI governance, and clear workflow return on investment. Forget broad promises; 96% of Canadian healthcare IT buyers mandate or heavily weight interoperability in upcoming RFPs, and 74% prohibit the use of Canadian protected health information for AI training without explicit written consent.

Editorial Team1 min
What Canadian health IT buyers want before they sign
Technology 6/16/2026

In vivo CRISPR therapy successfully reduces hereditary angioedema attacks in first Phase III trial

Intellia Therapeutics has announced groundbreaking Phase III results for lonvoguran ziclumeran (NTLA-2002), its in vivo CRISPR gene editing therapy for hereditary angioedema (HAE), marking the first successful late-stage trial of an in vivo CRISPR treatment. The HAELO trial demonstrated an 87% relative reduction in monthly HAE attacks compared to placebo, with 62% of treated patients remaining attack-free without ongoing prophylactic medication. This achievement, detailed by researchers from Amsterdam UMC and published in The New England Journal of Medicine, signals a potential paradigm shift toward single-dose, curative genetic interventions for a debilitating chronic condition.

Editorial Team1 min
In vivo CRISPR therapy successfully reduces hereditary angioedema attacks in first Phase III trial
Technology 6/16/2026

Your cheat sheet to Anthropic's latest drama with the White House

In an unprecedented move, the Trump administration's Commerce Department has forced AI powerhouse Anthropic to abruptly disable its newly launched, most advanced AI models, Fable 5 and Mythos 5, for all global users after issuing an Export Control Directive on June 12, 2026. Citing nebulous 'National Security Concerns' over a potential 'AI Jailbreak' in Fable 5 that could exploit software vulnerabilities, the directive marks a significant escalation from previous hardware restrictions to directly controlling deployed commercial AI models. This shock intervention comes as Anthropic was reportedly preparing for a nearly $1 trillion IPO, sending ripples of uncertainty through the burgeoning AI market.

Editorial Team1 min
Your cheat sheet to Anthropic's latest drama with the White House
Technology 6/15/2026

Anthropic export ban exposes Europe's AI sovereignty gap

The Trump administration has triggered a global scramble over AI governance, ordering Anthropic to restrict access to its cutting-edge Fable 5 and Mythos 5 AI models for all foreign nationals after Amazon researchers allegedly uncovered a critical vulnerability. This unprecedented export control directive, issued by U.S. Commerce Secretary Howard Lutnick on Friday, June 12, 2026, forced Anthropic to abruptly disable both models worldwide, exposing Europe's stark reliance on American-controlled frontier AI.

Editorial Team1 min
Anthropic export ban exposes Europe's AI sovereignty gap
Technology 6/15/2026

Early AI Vaccine Trial Could Reshape How Australia Plans for Future Outbreaks - eWeek

In a breakthrough that could fundamentally reshape global pandemic preparedness, an AI-designed universal coronavirus vaccine has successfully completed its first human safety trial, marking a historic milestone in vaccinology. The experimental vaccine, known as pEVAC-PS, was developed by the University of Cambridge and its spin-out DIOSynVax, demonstrating that an active vaccine component created entirely through computer simulations is safe for human use. This pioneering achievement signals a new era where artificial intelligence moves from research support to actively designing biological components for human trials, with Australia closely watching its implications for future outbreak strategies.

Editorial Team1 min
Early AI Vaccine Trial Could Reshape How Australia Plans for Future Outbreaks - eWeek
Technology 6/15/2026

'The paradox of the death gene': Stress defense mechanism that saves brain cells revealed

Scientists at the Daegu Gyeongbuk Institute of Science and Technology (DGIST) have uncovered a groundbreaking paradox: the p53 gene, universally known as the 'death gene' for its tumor-suppressing role, actually acts as a protective shield for brain cells under chronic stress. This pivotal research, led by Professor Yu Seong-woon and published in the journal Autophagy, reveals that p53 prevents the demise of hippocampal neural stem cells by inhibiting autophagic cell death, potentially unlocking a radically new approach to treating stress-related brain disorders.

Editorial Team1 min
'The paradox of the death gene': Stress defense mechanism that saves brain cells revealed
Technology 6/15/2026

Indian AI startups confront new risks after Anthropic pulls Fable 5

Anthropic, a leading US-based AI developer, abruptly withdrew access to its advanced models, Fable 5 and Mythos 5, for foreign nationals on June 12, 2026, following a direct order from the US government citing national security concerns. This unprecedented move, the first known instance of AI models being subjected to export controls, has sent shockwaves through India's burgeoning AI ecosystem, exposing the deep vulnerabilities of Indian startups heavily reliant on foreign foundational models.

Editorial Team1 min
Indian AI startups confront new risks after Anthropic pulls Fable 5
Technology 6/15/2026

Jio Platforms in global top20 of WIPO patent alliance list

Jio Platforms, the tech arm of Indian conglomerate Reliance Industries, has made a remarkable leap into the global top 20 of the World Intellectual Property Organisation's (WIPO) Patent Cooperation Treaty (PCT) rankings for 2025, positioning itself alongside established global tech giants like Huawei, Samsung, and Google. This unprecedented ascent of 320 places marks the first time an Indian company has achieved such a prominent standing in international patenting, signaling a critical pivot in India's innovation narrative.

Editorial Team1 min
Jio Platforms in global top20 of WIPO patent alliance list
Technology 6/15/2026

Satya Nadella warns AI could leave entire industries struggling if value stays with few companies - India Today

Microsoft CEO Satya Nadella has issued a stark warning that unchecked Artificial Intelligence could concentrate economic value among a handful of powerful foundation models, threatening to 'hollow out' entire industries and destabilize the political economy. In a detailed post titled 'A Frontier Without an Ecosystem Is Not Stable,' Nadella argues this mirrors the displacement seen during early globalization, where aggregate economic growth masked severe industry-specific job losses and expertise erosion. His intervention sharpens a growing debate over AI's true societal cost if its benefits are not broadly distributed.

Editorial Team1 min
Satya Nadella warns AI could leave entire industries struggling if value stays with few companies - India Today
Technology 6/15/2026

Chip woes stretch planning cycles: Ericsson India MD Nitin Bansal

Ericsson India, a key player in global telecom infrastructure, is drastically extending its operational planning horizons from the standard 18-36 months to an unprecedented three to five years. This strategic pivot, revealed by MD Nitin Bansal on June 14, 2026, is a direct response to persistent semiconductor shortages, exponentially rising component costs, and broad supply chain uncertainties exacerbated by geopolitical factors, including the West Asian conflict. The move underscores a profound shift in how major tech firms are navigating a volatile global manufacturing landscape, with long-term forecasting becoming paramount to ensure continuity.

Editorial Team1 min
Chip woes stretch planning cycles: Ericsson India MD Nitin Bansal
Technology 6/15/2026

Exercise decreases among people taking GLP-1 medication - FirstWord Pharma

A groundbreaking study presented at ENDO 2026 reveals a critical and unexpected side effect of GLP-1 medications: individuals taking these highly popular weight-loss drugs are significantly decreasing their physical activity levels. Utilizing real-world Fitbit data from the National Institutes of Health's All of Us Research Program, researchers found a measurable decline in daily step counts and moderate-to-vigorous physical activity, challenging the assumption that weight loss naturally leads to increased movement. This paradox presents a significant concern for long-term health outcomes, particularly the preservation of lean muscle mass.

Editorial Team1 min
Exercise decreases among people taking GLP-1 medication - FirstWord Pharma
Technology 6/14/2026

Tuberculosis may spread before people realize they are sick, a new study warns

A groundbreaking study published in Nature Communications on June 5, 2026, has upended long-held assumptions about tuberculosis transmission, revealing that asymptomatic individuals are significant drivers of its spread. Researchers Chen, Hu, and Horsburgh found that between 25.0% and 51.3% of new Mycobacterium tuberculosis (Mtb) infections in eastern China originated from patients showing no overt symptoms. This finding directly challenges traditional public health strategies that primarily focus on symptomatic, coughing individuals as the main source of contagion.

Editorial Team1 min
Tuberculosis may spread before people realize they are sick, a new study warns
Technology 6/14/2026

Las Vegas startup bets AI can transform heart disease detection

Las Vegas-based startup Medaica is set to disrupt cardiovascular care with the imminent direct-to-consumer launch of its AI-powered home heart exam kit, aiming to make early heart disease detection more accessible and affordable. The kit, featuring an FDA-cleared digital stethoscope and an AI-assisted cardiologist review, represents a significant push into proactive, at-home health screening at a time when cardiovascular disease remains the leading cause of death globally. This move could fundamentally shift how millions approach heart health, moving diagnostics out of the clinic and into patients' hands.

Editorial Team1 min
Las Vegas startup bets AI can transform heart disease detection
Technology 6/14/2026

Huawei Unveils HarmonyOS 7: AI Agents Reshape the OS as Xiaoyi Becomes the System's Intelligent Core - Pandaily

Huawei has officially unveiled HarmonyOS 7 at its annual Developer Conference, fundamentally transforming its proprietary operating system with a new 'Agent-native' architecture where its Xiaoyi assistant evolves into a formidable system-level AI agent. This pivot positions HarmonyOS 7 as an 'intent-driven' platform, boasting over 2,100 system capabilities and integrating thousands of third-party AI agents, directly challenging the established mobile OS giants like Apple and Google in the burgeoning AI era.

Editorial Team1 min
Huawei Unveils HarmonyOS 7: AI Agents Reshape the OS as Xiaoyi Becomes the System's Intelligent Core - Pandaily
Technology 6/14/2026

Two phones and an app: How Russians skirt Putin's digital iron curtain

Russians are increasingly adopting sophisticated, multi-device strategies to bypass the Kremlin's intensifying digital controls, including using two phones – one for state-sanctioned apps and another for encrypted foreign messengers. This comes as mobile internet shutdowns have hit major cities like Moscow since March 2026, WhatsApp was blocked nationwide in February, and Telegram has faced widespread throttling, driving citizens to increasingly convoluted technical solutions to maintain access to independent information and international communication.

Editorial Team1 min
Two phones and an app: How Russians skirt Putin's digital iron curtain
Technology 6/14/2026

OpenAI faces investigation from state attorneys general

A powerful coalition of 42 U.S. state attorneys general has launched a sweeping investigation into OpenAI, serving the artificial intelligence giant with a subpoena just days after its confidential Initial Public Offering filing. The wide-ranging probe, coordinated by the New York Attorney General's office, demands documents on everything from the company's advertising practices and handling of sensitive health data to its impact on minors and seniors. This unprecedented multi-state action signals a dramatic escalation in regulatory scrutiny for one of the world's leading AI developers, potentially redefining the landscape of responsible AI deployment.

Editorial Team1 min
OpenAI faces investigation from state attorneys general
Technology 6/14/2026

Genmab A/S: Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Genmab A/S has unveiled compelling new data at the European Hematology Association (EHA) 2026 Congress, demonstrating high response rates for its bispecific antibody, epcoritamab, in elderly patients with newly diagnosed Diffuse Large B-Cell Lymphoma (DLBCL). Results from the Phase 2 EPCOREDLBCL-3 trial showed a 67% Overall Response Rate (ORR) and a 58% Complete Response (CR) rate with epcoritamab monotherapy in this particularly vulnerable patient group. Concurrently, data from the Phase 1b/2 EPCORE NHL-2 trial highlighted an impressive 93% ORR and 86% CR rate for epcoritamab in combination with R-mini-CHOP, signalling a potential paradigm shift for first-line treatment in a population often unable to tolerate intensive standard chemotherapy.

Editorial Team1 min
Genmab A/S: Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Technology 6/14/2026

GLP-1 Initiation Associated With Increase in Hypotensive Events in Patients With Hypertension - HCPLive

A new study presented at the Endocrine Society (ENDO) Annual Meeting 2026 reveals that initiating GLP-1 receptor agonist therapy in patients with pre-existing hypertension is associated with a statistically significant increase in hypotensive events, including fainting, dizziness, and falls. This finding from Northwestern Medicine researchers challenges the widely held view of GLP-1s as uniformly beneficial for cardiovascular health, introducing a critical safety nuance for a large, vulnerable patient population already managing high blood pressure with multiple medications.

Editorial Team1 min
GLP-1 Initiation Associated With Increase in Hypotensive Events in Patients With Hypertension - HCPLive
Technology 6/13/2026

SpaceX Creates History, Becomes 6th Most Valuable US-Listed Company At $161 Share Price

SpaceX, the aerospace and AI powerhouse led by Elon Musk, roared onto the Nasdaq exchange on June 12, 2026, under the ticker SPCX, achieving a staggering $2.1 trillion market capitalization on its debut. Closing its first day at $160.95 per share after pricing at $135, the historic Initial Public Offering officially crowned Musk as the world's first trillionaire and positioned SpaceX as the sixth most valuable US-listed company. This unprecedented market entry shatters previous IPO records and signals a new era for the commercial space and artificial intelligence sectors.

Editorial Team1 min
SpaceX Creates History, Becomes 6th Most Valuable US-Listed Company At $161 Share Price
Technology 6/13/2026

Anthropic is pulling its two newest AI models after a U.S. government directive

Anthropic, the prominent AI developer, has abruptly disabled its two newest and most advanced artificial intelligence models, Claude Fable 5 and Mythos 5, for all global users following an unprecedented export control directive from the U.S. government. Issued by Commerce Secretary Howard Lutnick on Friday, June 12, 2026, just three days after their launch, the order cites unspecified national security concerns, marking a significant escalation in Washington's bid to control frontier AI technologies and raising immediate questions about future AI deployment.

Editorial Team1 min
Anthropic is pulling its two newest AI models after a U.S. government directive
‹ Prev1…3435363738…52Next ›

Page 36 of 52 · 1029 articles

ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies